Should Fortwin (pentazocine) be given to a patient who is acutely intoxicated with alcohol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fortwin (Pentazocine) Should NOT Be Given to Acutely Alcohol-Intoxicated Patients

Pentazocine (Fortwin) is contraindicated in patients with acute alcohol intoxication due to the severe risk of additive CNS and respiratory depression, which can lead to respiratory arrest and death.

Critical Safety Concerns

Additive CNS Depression

Alcohol and pentazocine both cause central nervous system depression. When combined, they produce synergistic respiratory depression that significantly increases mortality risk 1. The 2023 American Heart Association guidelines emphasize that mixed intoxications with CNS depressants are particularly dangerous and may not respond adequately to reversal agents 1.

Mixed Agonist-Antagonist Properties Create Additional Risk

Pentazocine is a mixed agonist-antagonist opioid that acts on kappa-opioid receptors while antagonizing mu-opioid receptors 2, 3. This unique pharmacology creates specific problems:

  • In alcohol-dependent patients, pentazocine can precipitate acute withdrawal symptoms if they have concurrent opioid use 2
  • The antagonist properties may worsen respiratory depression in the setting of alcohol intoxication 4
  • Pentazocine must be avoided in patients who may have polysubstance use, as it can displace other opioids and trigger withdrawal 2

Clinical Management Algorithm

Immediate Assessment

  1. Stabilize airway, breathing, and circulation first - this is the priority in any intoxicated patient 5, 6
  2. Check blood alcohol concentration (BAC) and perform capillary glucose immediately 7
  3. Perform complete examination looking for:
    • Respiratory rate and depth
    • Level of consciousness (Glasgow Coma Scale)
    • Signs of trauma (maintain low threshold for CT imaging) 7
    • Evidence of polysubstance use

Pain Management in Alcohol-Intoxicated Patients

If analgesia is required:

  • Use non-opioid analgesics first: NSAIDs like diclofenac or ketorolac 3
  • Avoid all mixed agonist-antagonist opioids (pentazocine, nalbuphine, butorphanol) 2
  • If opioid analgesia is absolutely necessary, use pure mu-agonists (morphine, fentanyl) in small, titrated doses with continuous monitoring 4
  • Administer analgesics in small repeated doses rather than large boluses to prevent exacerbation of respiratory depression 4

Monitoring Requirements

  • Continuous pulse oximetry and respiratory monitoring
  • Frequent reassessment (every 15-30 minutes initially) 7, 8
  • Be prepared for endotracheal intubation if respiratory depression worsens 1

Common Pitfalls to Avoid

  1. Never assume alcohol is the only intoxicant - polysubstance use is extremely common 1
  2. Do not give pentazocine "because it's a weaker opioid" - the mixed agonist-antagonist properties make it MORE dangerous, not less 2
  3. Avoid patient-controlled analgesia in intoxicated patients - they are not lucid enough to use it safely 4, 2
  4. Do not discharge until completely sober - patients must be re-evaluated when alcohol effects have resolved 7

Special Considerations for Alcohol Use Disorder

If the patient has underlying alcohol use disorder (which should be screened for using AUDIT questionnaire 9):

  • Benzodiazepines are the gold standard for alcohol withdrawal syndrome if it develops 9, 10, 9
  • Short-acting benzodiazepines (lorazepam, oxazepam) are preferred if hepatic dysfunction is present 9, 10, 9
  • Thiamine supplementation should be given to prevent Wernicke's encephalopathy 10
  • Refer to addiction services before discharge 5, 11

Bottom Line

The combination of pentazocine and alcohol creates life-threatening respiratory depression through additive CNS effects. The mixed agonist-antagonist properties of pentazocine add unpredictable risks, particularly in patients with polysubstance use or alcohol dependence. Use alternative analgesics (NSAIDs preferred, or pure mu-agonist opioids if absolutely necessary with intensive monitoring). Acute alcohol intoxication is a diagnosis of exclusion requiring meticulous examination and frequent reassessment 7, 8.

References

Research

Identification and management of acute alcohol intoxication.

European journal of internal medicine, 2023

Research

Alcohol: intoxication and poisoning - diagnosis and treatment.

Handbook of clinical neurology, 2014

Research

[Management of the drunken patient].

Revue medicale suisse, 2013

Related Questions

What is the appropriate assessment and initial management for acute alcohol poisoning?
What is the best treatment for a 36-year-old male presenting with agitation and nausea after a day of binge alcohol consumption (≈750 mL/day) with stable vital signs?
Does acute alcohol intoxication cause bidirectional nystagmus?
How to emergently treat severe ethanol intoxication with a blood alcohol concentration of 0.395 and hypokalemia (potassium level of 2.3 mEq/L)?
What lab values are concerning in alcohol poisoning?
When should an adult undergo a dual‑energy X‑ray absorptiometry (DEXA) scan and how are the T‑score results interpreted for osteoporosis or osteopenia?
How can we create a detailed taper schedule, including doses and timing, for an adult patient on lisdexamfetamine 110 mg daily and methylphenidate OROS (osmotic release oral system) 72 mg daily, with prior amphetamine‑induced psychosis, major depressive disorder in remission on duloxetine 120 mg daily, psoriatic arthritis treated with indomethacin 150 mg daily and topical clobetasol, and hypertension controlled with nebivolol 5 mg daily and losartan 50 mg daily, using the available medications (methadone, lisdexamfetamine 50 mg/30 mg/20 mg, Concerta 36 mg/18 mg, modafinil, diazepam, clonazepam, alprazolam, clotiazepam, bromazepam, aripiprazole, lurasidone, amisulpride, brexpiprazole, nitrazepam, zolpidem, eszopiclone)?
In a patient with sinus bradycardia, an abnormal electrocardiogram suggesting an old inferior myocardial infarction, and two weeks of chest pain, should I send them to the emergency department or continue monitoring in primary care?
What does the ankle‑brachial index (ABI) assess?
In a patient with depression on fluoxetine 20 mg PO daily who reports modest improvement, decreased motivation, missed doses, disrupted sleep, minimal anxiety, and a recent episode of passive suicidal ideation, how should the fluoxetine be managed and what augmentation strategy should be considered?
What is the recommended evaluation and treatment plan for a patient being considered for lung transplantation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.